Molecular basis of quantitative fibrinogen disorders in 27 patients from India

Haemophilia

Volumn 19, Issue 4, 2013, Pages 611-618

  Sumitha, E ^a   Jayandharan, G R ^a   Arora, N ^a   Abraham, A ^a   David, S ^a   Devi, G S ^a   Shenbagapriya, P ^a   Nair, S C ^a   George, B ^a   Mathews, V ^a   Chandy, M ^a   Viswabandya, A ^a   Srivastava, A ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Fibrinogen; Genotype phenotype; Mutation

Indexed keywords

FIBRINOGEN; GENOMIC DNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING TIME; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA CONFORMATION; DNA SCREENING; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; FRAMESHIFT MUTATION; GEL ELECTROPHORESIS; HUMAN; INDIA; INFANT; MALE; MISSENSE MUTATION; NEWBORN; NONSENSE MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE GENETICS; RNA SPLICING; SCHOOL CHILD;

ADOLESCENT; ADULT; AFIBRINOGENEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRINOGEN; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; YOUNG ADULT;

EID: 84879463196     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12143     Document Type: Article

References (23)

1. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-904.
2. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114: 261-74.
3. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 2001; 936: 11-30.
4. Herrick S, Blanc-Brude O, Gray A, Laurent G. Fibrinogen. Int J Biochem Cell Biol 1999; 31: 741-6.
5. Neerman-Arbez M, De Moerloose P. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations. Hum Mutat 2007; 28: 540-53.
6. Matsuda M, Sugo T. Hereditary disorders of fibrinogen. Ann N Y Acad Sci 2001; 936: 65-88.
7. Asselta R, Spena S, Duga S, Tenchini ML. Molecular genetics of quantitative fibrinogen disorders. Cardiovasc Hematol Agents Med Chem 2007; 5: 163-73.
8. Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost 2006; 4: 2115-29.
9. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
10. Viswabandya A, Baidya S, Nair SC et al. Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India. Haemophilia 2012; 18: e195-200.
11. Sachs UJH, Kroll H, Matzdorff AC, Berghöfer H, Löpez JA, Santoso S. Bernard-Soulier syndrome due to the homozygous Asn-45Ser mutation in GPIX: an unexpected, frequent finding in Germany. Br J Haematol 2003; 123: 127-31.
12. Jayandharan G, Viswabandya A, Baidya S et al. Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T->G factor X gene mutations are responsible for congenital factor X deficiency in patients of Nepali and Indian origin. J Thromb Haemost 2005; 3: 1482-7.
13. Jayandharan G, Nelson EJR, Baidya S, Chandy M, Srivastava A. A new multiplex PCR and conformation-sensitive gel electrophoresis strategy for mutation detection in the platelet glycoprotein alphaIIb and beta3 genes. J Thromb Haemost 2007; 5: 206-9.
14. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002; 30: 3894-900.
15. Sunyaev S, Ramensky V, Bork P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet 2000; 16: 198-200.
16. Sunyaev S, Ramensky V, Koch I, Lathe W IIIrd, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001; 10: 591-7.
17. Robert-Ebadi H, De Moerloose P, El Khorassani M, El Khattab M, Neerman-Arbez M. A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream. Blood Coagul Fibrinolysis 2009; 20: 385-7.
18. Attanasio C, De Moerloose P, Antonarakis SE, Morris MA, Neerman-Arbez M. Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4+1G->T. Blood 2001; 97: 1879-81.
19. Maghzal GJ, Brennan SO, Fellowes AP, Spearing R, George PM. Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg->His (Fibrinogen Merivale). Biochim Biophys Acta 2003; 1645: 146-51.
20. Brennan SO, Wyatt JM, May S, De Caigney S, George PM. Hypofibrinogenemia due to novel 316 Asp -> Tyr substitution in the fibrinogen Bbeta chain. Thromb Haemost 2001; 85: 450-3.
21. Vu D, Bolton-Maggs PHB, Parr JR, Morris MA, De Moerloose P, Neerman-Arbez M. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion. Blood 2003; 102: 4413-5.
22. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999; 107: 204-6.
23. Acharya SS, Coughlin A, Dimichele DM, Group TNARBDS. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248-56.